Total submissions: 11
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000710516 | SCV000342299 | uncertain significance | not provided | 2016-05-20 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000263557 | SCV000354303 | benign | Hypophosphatasia | 2018-01-13 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. |
Gene |
RCV000710516 | SCV000566451 | likely benign | not provided | 2021-02-15 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 21956185, 27042741, 30564332, 32803091) |
Athena Diagnostics | RCV000710516 | SCV000840754 | benign | not provided | 2017-09-30 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000710516 | SCV001110181 | benign | not provided | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV001820834 | SCV002066752 | likely benign | not specified | 2021-11-22 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002519300 | SCV003682748 | benign | Inborn genetic diseases | 2022-01-11 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV000710516 | SCV004123405 | likely benign | not provided | 2024-07-01 | criteria provided, single submitter | clinical testing | ALPL: BS2 |
JKU Lab, |
RCV000263557 | SCV004174863 | uncertain significance | Hypophosphatasia | 2022-10-19 | criteria provided, single submitter | clinical testing | Further details and the ACMG criteria applied can be looked up in the ALPL gene variant database. https://alplmutationdatabase.jku.at/ |
Natera, |
RCV000263557 | SCV001463897 | benign | Hypophosphatasia | 2020-01-11 | no assertion criteria provided | clinical testing | |
Prevention |
RCV004549605 | SCV004774190 | likely benign | ALPL-related disorder | 2024-02-02 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |